NMC Notifies Final Decision on 195 Applications to Start, Increase PG Medical Seats from 41 Institutes

Published On 2024-05-22 06:58 GMT   |   Update On 2024-05-22 09:46 GMT

National Medical Commission (NMC)

New Delhi: The Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has notified its final decision on 195 more applications for starting new postgraduate medical courses and an increase of PG medical seats in the existing PG medical courses for the academic year 2024-2025.

NMC received these applications from altogether 41 medical colleges. Among these, 139 applications were for starting new PG Medical Courses and 56 applications were for increase of seats in the PG medical courses.

Issuing a notice on May 21, 2024, the Apex Medical Regulator informed that the final decision of MARB in respect of these applications has been communicated through e-mail to the concerned Medical Institutions/Colleges for information and necessary action by them within the stipulated timeline.

"In continuation of MARB’s Public Notice dated the 28th April 2024, with reference to applications from medical institutions for start or increase of PG medical courses/seats, it is informed that final decision of MARB in respect of 195 more applications (for starting of new PG Medical courses and increase of seats in PG Medical courses for the Academic year: 2024-25) has been communicated through e-mail IDs (as mentioned in online applications) to the Medical Institutions/Colleges concerned for information and necessary action by them within the stipulated timeline," NMC mentioned in the notice.

"A list containing application number of each of the aforesaid 195 applications (139 applications for starting of new PG Medical courses and 56 applications for increase of seats in PG Medical courses) is attached with this public notice for general information," it further mentioned.

Medical Dialogues had earlier reported that recently through a notice dated 28.04.2024, NMC had sent its final decision to 18 medical colleges in respect of 101 applications for the starting of new PG medical courses and an increase of seats for the academic year 2024-2025. At that time, the Commission had informed that communications of the final decision in respect of remaining applications would be sent in due course. Again on 04.05.2024, NMC issued another notice and communicated its final decision to 31 medical institutes in respect of 153 applications.

Thereafter, through a notice dated 13.05.2024, NMC notified its final decision on 158 more applications from 32 medical institutes for starting new PG medical courses and increasing PG medical seats.

Referring to these earlier notices, NMC mentioned in its recent notice dated 21.05.2024, "It may be recalled that vide MARB’s Public notice of even number dated the 28th April 2024, 4th May 2024, 10th May 2024 & 18th May 2024 it was informed that final decision in respect of 413 online PG Medical course applications (297 applications for starting of new PG Medical courses and 116 applications for increase of seats in PG Medical courses) had already been communicated through the email IDs (as mentioned in online applications) to the Medical Institutions/Colleges concerned."

NMC further added that the "Final decision in respect of remaining applications received online will be sent in due course."

To view the NMC notice, click on the link below:

https://medicaldialogues.in/pdf_upload/nmc-pg-medical-courses-238916.pdf

Also Read: NMC notifies its final decision on 158 applications to start new PG medical courses, increase PG medical seats

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News